BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maharshak N, Halfon P, Deutsch V, Peretz H, Berliner S, Fishman S, Zelber-Sagi S, Rozovski U, Leshno M, Oren R. Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation. World J Gastroenterol 2011; 17(45): 5007-5013 [PMID: 22174551 DOI: 10.3748/wjg.v17.i45.5007]
URL: https://www.wjgnet.com/1007-9327/full/v17/i45/5007.htm
Number Citing Articles
1
Martin Zalesak, Kevin Francis, Alex Gedeon, John Gillis, Kyle Hvidsten, Phyllis Kidder, Hong Li, Derek Martyn, Leslie Orne, Amanda Smith, Ann Kwong, Yury E. Khudyakov. Current and Future Disease Progression of the Chronic HCV Population in the United StatesPLoS ONE 2013; 8(5): e63959 doi: 10.1371/journal.pone.0063959
2
Jessica P.E. Davis, Stephen H. Caldwell. Healing gone wrong: convergence of hemostatic pathways and liver fibrosis?Clinical Science 2020; 134(16): 2189 doi: 10.1042/CS20191102
3
Mario D'Amico, Francesca Pasta, Linda Pasta. Thrombophilic genetic factors PAI-1 4G-4G and MTHFR 677TT as risk factors of alcohol, cryptogenic liver cirrhosis and portal vein thrombosis, in a Caucasian populationGene 2015; 568(1): 85 doi: 10.1016/j.gene.2015.05.034
4
Elisabeth P. C. Plompen, Jeoffrey N. L. Schouten, Harry L. A. Janssen. Role of anticoagulant therapy in liver diseaseHepatology International 2013; 7(2): 369 doi: 10.1007/s12072-013-9427-2
5
María Monereo Muñoz, Selena Gala Aguilera García, Raquel de la Barreda Heusser, Emilio González Arnay, Sonia García Hernández, Emilio González Reimers. Cryptogenetic liver cirrhosis and prothrombotic mutations - A mere association?Revista Española de Enfermedades Digestivas 2016;  doi: 10.17235/reed.2016.3871/2015
6
L. G. Poole, A. Pant, K. S. Baker, A. K. Kopec, H. M. Cline‐Fedewa, S. E. Iismaa, M. J. Flick, J. P. Luyendyk. Chronic liver injury drives non‐traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminaseJournal of Thrombosis and Haemostasis 2019; 17(1): 113 doi: 10.1111/jth.14330
7
Niccolò Bitto, Eleonora Liguori, Vincenzo Mura. Coagulation, Microenvironment and Liver FibrosisCells 2018; 7(8): 85 doi: 10.3390/cells7080085
8
Lauren G. Poole, Asmita Pant, Holly M. Cline‐Fedewa, Kurt J. Williams, Bryan L. Copple, Joseph S. Palumbo, James P. Luyendyk. Liver fibrosis is driven by protease‐activated receptor‐1 expressed by hepatic stellate cells in experimental chronic liver injuryResearch and Practice in Thrombosis and Haemostasis 2020; 4(5): 906 doi: 10.1002/rth2.12403
9
Linda Pasta, Francesca Pasta. PAI-1 4G-4G and MTHFR 677TT in non-hepatitis C virus/hepatitis B virus-related liver cirrhosisWorld Journal of Hepatology 2015; 7(29): 2920-2926 doi: 10.4254/wjh.v7.i29.2920
10
Jann‐Inn Tzeng, Mei‐Fen Chen, Hsien‐Hui Chung, Juei‐Tang Cheng. Silymarin Decreases Connective Tissue Growth Factor to Improve Liver Fibrosis in Rats Treated with Carbon TetrachloridePhytotherapy Research 2013; 27(7): 1023 doi: 10.1002/ptr.4829
11
Emilio González-Reimers, Geraldine Quintero-Platt, Candelaria Martín-González, Onán Pérez-Hernández, Lucía Romero-Acevedo, Francisco Santolaria-Fernández. Thrombin activation and liver inflammation in advanced hepatitis C virus infectionWorld Journal of Gastroenterology 2016; 22(18): 4427-4437 doi: 10.3748/wjg.v22.i18.4427
12
Asmita Pant, Anna K. Kopec, James P. Luyendyk. Role of the blood coagulation cascade in hepatic fibrosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 315(2): G171 doi: 10.1152/ajpgi.00402.2017
13
Jessica P. E. Davis, Amy G. Ogurick, Carrie E. Rothermel, Min-Woong Sohn, Nicolas M. Intagliata, Patrick G. Northup. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunting for Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-AnalysisClinical and Applied Thrombosis/Hemostasis 2019; 25: 107602961988802 doi: 10.1177/1076029619888026
14
Claude Lentschener, Claire Flaujac, Firas Ibrahim, Isabelle Gouin-Thibault, Marie Bazin, Philippe Sogni, Charles-Marc Samama. Assessment of haemostasis in patients with cirrhosisEuropean Journal of Anaesthesiology 2016; 33(2): 126 doi: 10.1097/EJA.0000000000000322
15
Elisabeth P.C. Plompen, Sarwa Darwish Murad, Bettina E. Hansen, Daan W. Loth, Jeoffrey N.L. Schouten, Pavel Taimr, Albert Hofman, André G. Uitterlinden, Bruno H. Stricker, Harry L.A. Janssen, Frank W.G. Leebeek. Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general populationJournal of Hepatology 2015; 63(6): 1459 doi: 10.1016/j.jhep.2015.07.026
16
Laura Turco, Filippo Schepis, Erica Villa. The Role of Anticoagulation in Treating Portal HypertensionCurrent Hepatology Reports 2018; 17(3): 200 doi: 10.1007/s11901-018-0406-x
17
Levent Filik. Factor XIII Val34Leumutation and liver fibrosis rate in viral hepatitisHepatology Research 2012; 42(11): 1154 doi: 10.1111/j.1872-034X.2012.01042.x
18
E E Starostina, L M Samokhodskaya, T P Rozina, T N Krasnova, E B Yarovaya, N A Mukhin. Role of polymorphic markers for the genes of hemostasis and platelet receptors in liver fibrosis progression in patients with chronic hepatitis CTerapevticheskii arkhiv 2016; 88(8): 93 doi: 10.17116/terarkh201688893-98